Edges in Network
| Network | GSE14208_egf1520 - GSE14208 - SiGN-BN HC+Bootstrap |
| Network Description | Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy |
| Node | UBE2L6 |
| Upstream (Parents) |
|---|
| (<<) BMPR1A → UBE2L6 |
| (<<) CASP1 → UBE2L6 |
| (<<) CASP4 → UBE2L6 |
| (<<) GSTK1 → UBE2L6 |
| (<<) HLA-G → UBE2L6 |
| (<<) IRF1 → UBE2L6 |
| (<<) ISG20 → UBE2L6 |
| (<<) KYNU → UBE2L6 |
| (<<) LPXN → UBE2L6 |
| (<<) MYCN → UBE2L6 |
| (<<) PRKAA1 → UBE2L6 |
| (<<) RAC2 → UBE2L6 |
| (<<) RHOG → UBE2L6 |
| Downstream (Children) |
|---|
| UBE2L6 → BCL2L1 (>>) |
| UBE2L6 → CDC42EP1 (>>) |
| UBE2L6 → CXCL3 (>>) |
| UBE2L6 → FAM48A (>>) |
| UBE2L6 → FGFR3 (>>) |
| UBE2L6 → FZD1 (>>) |
| UBE2L6 → GBP2 (>>) |
| UBE2L6 → GLRX (>>) |
| UBE2L6 → GNG12 (>>) |
| UBE2L6 → GRB10 (>>) |
| UBE2L6 → HLA-A (>>) |
| UBE2L6 → HLA-F (>>) |
| UBE2L6 → HSPA2 (>>) |
| UBE2L6 → IFITM3 (>>) |
| UBE2L6 → JAK2 (>>) |
| UBE2L6 → MAP3K9 (>>) |
| UBE2L6 → MTSS1 (>>) |
| UBE2L6 → NAV2 (>>) |
| UBE2L6 → PRKCQ (>>) |
| UBE2L6 → SOCS1 (>>) |
| UBE2L6 → STAT1 (>>) |
| UBE2L6 → TCF7L1 (>>) |
| UBE2L6 → TNF (>>) |
